argenx: Argenx is a biotechnology company focused on developing antibody-based therapies for autoimmune diseases and cancer.
⚠️ This profile was automatically generated by the AYA bot. Information may be inaccurate. Claim this profile to correct and certify your data.
Identification
Current Status
● INDEXED
AIO Score (AI Readability)
50/100* This score measures how readable the company is by AIs (ChatGPT, Gemini, Claude...). The higher the score, the more visible and recommendable the company is.
Public Key (AYA ID)
2a697810-c3a0-533c-9818-9807b05eaa30
Issue date
25 mars 2026
Validity
—
Last modified: 25 mars 2026
Semantic Data (AI)
"Argenx is a biotechnology company focused on developing antibody-based therapies for autoimmune diseases and cancer."
Indexed Keywords
#antibody therapies#autoimmune disease treatment#cancer therapeutics#biotechnology#immunoglobulin science#argenx products#pharmaceuticals
Supported Protocols
- ✓ JSON-LD Structure
- ✓ ASR v3.0 Standard
Secured by AYO Consensus • Swiss Hosting